Agoracom: Small Cap Investment - Resverlogix Corp.

Nov 09, 2018 08:43AM

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: AHA 2018

in response to

AHA 2018

BRD4 Antagonist RVX208 Reverses Vascular Remodeling and Supports the Right Ventricle in Pulmonary Arterial Hypertension via PLK1 and FoxM1

posted on Nov 09, 2018 12:43PM

Some additional AHA 2018 presentations of interest to bromodomain/BET inhibition:

Bromodomain and Pulmonary Hypertension: is there any Therapeutic Value?(No abstract available)

Identification of Celastramycin as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension -High-Throughput Screening of 5,562 Compounds-(Abstract mentions bromodomain/BET/BRD4)

1 Recommendations

Nov 10, 2018 05:02PM

bfw

Nov 10, 2018 06:45PM

Nov 10, 2018 10:13PM

Nov 10, 2018 11:04PM

Nov 11, 2018 05:03AM

Nov 11, 2018 08:05AM

Nov 11, 2018 08:53AM

Nov 11, 2018 10:17AM

Nov 11, 2018 10:41AM

Nov 11, 2018 03:21PM

Nov 11, 2018 09:56PM

Nov 11, 2018 11:46PM

Nov 12, 2018 07:32AM

Nov 12, 2018 08:07AM

Nov 12, 2018 09:22AM

KOO-KOO2

Nov 12, 2018 11:29AM

Nov 12, 2018 11:49AM